110-43-0

应用筛选条件

关键词:'110-43-0'

显示 1-4 共 4 条结果关于 "110-43-0" 范围论文

Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial.

Peter Daley et al.

The Lancet. Infectious diseases, 15(5), 528-534 (2015-04-13)

Vitamin D has immunomodulatory effects that might aid clearance of mycobacterial infection. We aimed to assess whether vitamin D supplementation would reduce time to sputum culture conversion in patients with active tuberculosis. We did this randomised, double-blind, placebo-controlled, superiority trial

Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial.

D Nicholas Bateman et al.

Lancet (London, England), 383(9918), 697-704 (2013-12-03)

Paracetamol poisoning is common worldwide. It is treated with intravenous acetylcysteine, but the standard regimen is complex and associated with frequent adverse effects related to concentration, which can cause treatment interruption. We aimed to ascertain whether adverse effects could be

[The C(-1562)T polymorphism in the promoter of the matrix metalloproteinase-9 (MMP-9) gene and coronary atherosclerosis].

Jarosław Goracy et al.

Polskie Archiwum Medycyny Wewnetrznej, 110(5), 1275-1281 (2006-06-02)

Atherosclerosis of coronary arteries is a main cause of ischaemic heart disease (IHD). Matrix metalloproteinases, a super-family of zink-dependent enzymes, which are involved in the pathogenesis of atherosclerosis by the activation of migration and proliferation of smooth muscle cells and

Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy.

V B Sørensen et al.

Clinical science (London, England : 1979), 95(6), 709-717 (1998-12-01)

1. Our objective was to compare the effect of a long-acting calcium antagonist (nisoldipine) compared with an angiotensin-converting enzyme inhibitor (lisinopril) on the non-neurogenic regulation of the microvascular blood flow in hypertensive Type I diabetes patients with diabetic nephropathy.2. We

1/1